Yunping Lu

476 total citations
22 papers, 406 citations indexed

About

Yunping Lu is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Yunping Lu has authored 22 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Yunping Lu's work include Virus-based gene therapy research (4 papers), Cancer Research and Treatments (3 papers) and Cell death mechanisms and regulation (3 papers). Yunping Lu is often cited by papers focused on Virus-based gene therapy research (4 papers), Cancer Research and Treatments (3 papers) and Cell death mechanisms and regulation (3 papers). Yunping Lu collaborates with scholars based in China, United States and Taiwan. Yunping Lu's co-authors include Ding Ma, Jianfeng Zhou, Hui Xing, Xiangyi Ma, Shixuan Wang, Gang Xu, Shixuan Wang, Danfeng Luo, Qinglei Gao and Fang Zheng and has published in prestigious journals such as Clinical Cancer Research, Biochemical and Biophysical Research Communications and Chemical Engineering Science.

In The Last Decade

Yunping Lu

22 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yunping Lu China 10 266 107 64 46 46 22 406
Diala El Khoury France 8 395 1.5× 90 0.8× 77 1.2× 52 1.1× 45 1.0× 10 540
Jill Bayliss United States 11 189 0.7× 96 0.9× 59 0.9× 47 1.0× 29 0.6× 19 471
Charles H. Adelmann United States 9 309 1.2× 78 0.7× 64 1.0× 39 0.8× 67 1.5× 13 472
Anna Fiszer-Kierzkowska Poland 10 294 1.1× 73 0.7× 111 1.7× 44 1.0× 28 0.6× 17 520
Samuel Amintas France 10 275 1.0× 122 1.1× 88 1.4× 31 0.7× 36 0.8× 27 441
B.V. Harmon Australia 7 330 1.2× 93 0.9× 46 0.7× 58 1.3× 81 1.8× 8 592
Shruti Pandita United States 10 349 1.3× 97 0.9× 60 0.9× 28 0.6× 85 1.8× 16 512
Sen Peng United States 12 221 0.8× 91 0.9× 111 1.7× 46 1.0× 47 1.0× 26 427
Rahul Thorat India 15 337 1.3× 109 1.0× 90 1.4× 38 0.8× 42 0.9× 40 488
Gitanjali Jayachandran United States 11 338 1.3× 159 1.5× 109 1.7× 61 1.3× 65 1.4× 27 522

Countries citing papers authored by Yunping Lu

Since Specialization
Citations

This map shows the geographic impact of Yunping Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunping Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunping Lu more than expected).

Fields of papers citing papers by Yunping Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunping Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunping Lu. The network helps show where Yunping Lu may publish in the future.

Co-authorship network of co-authors of Yunping Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yunping Lu. A scholar is included among the top collaborators of Yunping Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunping Lu. Yunping Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Chen, Xiao Yang, Yue Zhou, et al.. (2023). Thermal-grinding supramolecular network loaded with paeonol for treatment of skin eczema. Chemical Engineering Science. 281. 119096–119096. 2 indexed citations
2.
Lu, Yunping, et al.. (2022). Exploring the Workplace Bullying of Indonesian Caregivers and Its Influencing Factors in Taiwan. International Journal of Environmental Research and Public Health. 19(8). 4909–4909. 3 indexed citations
3.
Ma, Xiangyi, Shu Li, Danfeng Luo, et al.. (2013). [Antitumor and antimetastatic effect of antimicrobial peptide conjugated with tumor homing peptide TMTP1 on the transplanted prostate cancer and gastric cancer in nude mice].. PubMed. 35(10). 737–41. 2 indexed citations
4.
Liao, Shujie, Dongrui Deng, Weina Zhang, et al.. (2012). Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo. Oncology Reports. 29(1). 95–102. 30 indexed citations
5.
Ma, Xiangyi, Peng Lv, Yiqun Zhang, et al.. (2012). DT390-triTMTP1, a Novel Fusion Protein of Diphtheria Toxin with Tandem Repeat TMTP1 Peptide, Preferentially Targets Metastatic Tumors. Molecular Pharmaceutics. 10(1). 115–126. 18 indexed citations
6.
Su, Wenjing, Lei Huang, Qilin Ao, et al.. (2011). Noscapine sensitizes chemoresistant ovarian cancer cells to cisplatin through inhibition of HIF-1α. Cancer Letters. 305(1). 94–99. 37 indexed citations
7.
Yang, Wanhua, Danfeng Luo, Shixuan Wang, et al.. (2008). TMTP1, a Novel Tumor-Homing Peptide Specifically Targeting Metastasis. Clinical Cancer Research. 14(17). 5494–5502. 96 indexed citations
8.
Xing, Hui, Xiaobing Han, Xiaoyan Shi, et al.. (2008). Apoptosis of HeLa cells induced by cisplatin and its mechanism. Journal of Huazhong University of Science and Technology [Medical Sciences]. 28(2). 197–199. 21 indexed citations
9.
Han, Xiaobing, Ling Xi, Hui Wang, et al.. (2008). The potassium ion channel opener NS1619 inhibits proliferation and induces apoptosis in A2780 ovarian cancer cells. Biochemical and Biophysical Research Communications. 375(2). 205–209. 42 indexed citations
10.
Wu, Huijuan, Danhui Weng, Hui Xing, Yunping Lu, & Ding Ma. (2007). Reversal of multidrug resistance and inhibition of phosphorylation of AKT in human ovarian cancer cell line by wild-type PTEN gene. Journal of Huazhong University of Science and Technology [Medical Sciences]. 27(6). 713–716. 1 indexed citations
12.
Li, Fang, Meng Li, Jianfeng Zhou, et al.. (2005). Reversing chemoresistance in cisplatin-resistant human ovarian cancer cells: A role of c-Jun NH2-terminal kinase 1. Biochemical and Biophysical Research Communications. 335(4). 1070–1077. 24 indexed citations
13.
Han, Zhiqiang, Gang Xu, Jianfeng Zhou, et al.. (2005). Inhibition of Motile and Invasive Properties of Ovarian Cancer Cells by ASODN Against Rho-associated Protein Kinase. Cell Communication & Adhesion. 12(1-2). 59–69. 6 indexed citations
14.
Wang, Beibei, Gang Chen, Fujun Li, et al.. (2005). Inhibitory effect of coxsackie adenovirus receptor on invasion and metastasis phenotype of ovarian cancer cell line SKOV3. Current Medical Science. 25(1). 85–87. 14 indexed citations
15.
Gao, Qinglei, Ding Ma, Shixuan Wang, et al.. (2004). Related Study on the Nm23-H1 Gene Expression in the Model of Ovarian Carcinoma Cell Lines with High Frequent Metastasis. The Chinese-German Journal of Clinical Oncology. 3(2). 2 indexed citations
16.
Yang, Xiaokui, Fang Zheng, Hui Xing, et al.. (2004). Resistance to chemotherapy-induced apoptosis via decreased caspase-3 activity and overexpression of antiapoptotic proteins in ovarian cancer. Journal of Cancer Research and Clinical Oncology. 130(7). 423–8. 81 indexed citations
17.
Chen, Gang, Jing Li, Fujun Li, et al.. (2004). Inhibitory effects of anti-sense PTTG on malignant phenotype of human ovarian carcinoma cell line SK-OV-3. Current Medical Science. 24(4). 369–372. 13 indexed citations
18.
Ling, Xi, et al.. (2004). Dysregulation of the TGF-β postreceptor signaling pathway in cell lines derived from primary or metastatic ovarian cancer. Current Medical Science. 24(1). 62–65. 3 indexed citations
19.
Lu, Yunping, Ali Zhang, Shixuan Wang, et al.. (2002). [Role of vascular endothelial growth factor overexpression in ovarian tumor invasion and mechanism].. PubMed. 37(5). 294–7. 1 indexed citations
20.
Wang, Shixuan, et al.. (1998). Clinical implication of serum sIL-2R levels in ovarian cancer. Current Medical Science. 18(2). 126–128. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026